Complete remission in leptomeningeal metastasis of NSCLC with rare EGFR-SEPT14 fusion treated with osimertinib combined with intrathecal chemotherapy with pemetrexed
This study presented the first case of NSCLC-LM harboring particular EGFR-SEPT14 fusions, who showed a durable response to osimertinib and intrathecal pemetrexed, providing a potential therapeutic option for NSCLC-LM patients with this particular mutation.
Source: Anti-Cancer Drugs - Category: Cancer & Oncology Tags: Case Reports Source Type: research
More News: Abraxane | Adenocarcinoma | Alimta | Avastin | Brain | Cancer | Cancer & Oncology | Chemotherapy | Cytology | Genetics | Headache | Lung Cancer | Migraine | Neurology | Non-Small Cell Lung Cancer | Study | Tarceva